Otonix 40 mg (Tablet (Enteric Coated))
Unit Price: ৳ 5.00 (50's pack: ৳ 250.00)
Medicine Details
Category | Details |
---|---|
Generic | Pantoprazole sodium |
Company | Peoples pharma ltd |
Also available as |
Product Attributes
- Title:
- Otonix 40 mg Tablet
- Categories:
- Medicines
- Pharmaceuticals
- Description:
- Proton pump inhibitor for acid suppression
- Dosage Form:
- Tablet
- Therapeutic Class:
- Proton Pump Inhibitor
- Indications:
- Peptic ulcer diseases
- Gastroesophageal reflux diseases
- Ulcer induced by NSAIDs
- Eradication of Helicobacter pylori
- Zollinger-Ellison Syndrome
- Mode of Action:
- Suppresses the final step in gastric acid production by binding to H+/K+ATPase enzyme system
- Dosage & Administration:
- Oral administration for various conditions
- Dosages for maintenance and initial treatment
- IV injection dosages for different conditions
- Interaction:
- No significant drug interactions observed in clinical studies
- Contraindications:
- Known hypersensitivity to any of the formulation components
- Side Effects:
- Common side effects include headache and diarrhea
- Rare side effects include abdominal pain, flatulence, rash, insomnia, hyperglycemia
- Pregnancy & Lactation:
- US FDA Pregnancy Category B
- Excreted in human milk
- Precautions & Warnings:
- Tablet should not be split, chewed, or crushed
- Long-term use may lead to malabsorption of Vitamin B12 and increase risk of osteoporosis
- Overdose Effects:
- No known symptoms of overdosage in humans
- Highly protein bound and not dialyzable
- Storage Conditions:
- Store in a dry place, away from light and heat
- Keep out of reach of children
- Chemical Structure:
- Molecular Formula: C16H15F2N3O4S
- Reconstitution:
- Directions for IV injection and IV infusion
- Common Questions:
- What is the tablet used for?
- Dosage frequency
- Storage and disposal instructions
- Effects on older adults
- Onset of action
- Safety concerns during pregnancy and breastfeeding
- Side effects
- Missed dose instructions
- Use Instructions:
- Take tablet orally with water
- Follow prescribed dosages
- Do not alter tablet form before consumption
- Safety Information:
- Caution against splitting, chewing, or crushing the tablet
- Monitoring for side effects like headache and diarrhea
- Special Precautions:
- Long-term use may lead to malabsorption of Vitamin B12
- Increased risk of osteoporosis-related disorders
- Risk Factors:
- Known hypersensitivity to tablet components
- Potential drug interactions
- Chemical Composition:
- Contains Pantoprazole as the active ingredient
- Mechanism of Action:
- Binds to H+/K+ ATPase enzyme system to inhibit gastric acid secretion
- Duration of Treatment:
- Treatment duration varies based on the condition
- Maintenance Dosage:
- 20 mg to 40 mg daily for certain conditions
- Treatment Regimen:
- 4-week initial treatment with potential extension based on healing progress
- IV Injection Guidelines:
- Dosage and duration for specific ulcer and reflux disease conditions
- IV Infusion Precautions:
- Reconstitution steps and storage guidelines for IV administration
- Human Milk Excretion:
- Presence of drug components in breast milk
- Safety Measures:
- Keep medication out of reach of children
- Avoid exposure to light and heat for storage
- Symptom Management:
- No specific therapy recommended for overdosage
- Emphasize symptomatic and supportive care
- Pregnancy Classification:
- FDA Pregnancy Category B for Pantoprazole
- Drug Absorption Risks:
- Potential risk of malabsorption of Vitamin B12 with long-term use
- Patient Instructions:
- Avoid altering tablet form before consumption
- Consult physician for dosage and treatment duration
- Effects on Bone Health:
- Potential risk of osteoporosis with prolonged use in older adults
- Formulation Components:
- Comprised of Pantoprazole and inactive ingredients
- Monitoring Recommendations:
- Regular assessment for side effects and response to treatment
- Gastric Acid Control:
- Effective suppression of basal and stimulated acid secretion
- Erosive Esophagitis Treatment:
- Specific dosages for reflux disease with esophageal damage
- Medication Discontinuation:
- Considerations for nursing mothers due to excretion in human milk
- Dose Adjustment:
- Individualized dosing for Zollinger-Ellison Syndrome based on response
- Acid Aspiration Profile:
- Prophylactic dosages for acid aspiration prevention
- Pathological Conditions:
- Management guidelines for Zollinger-Ellison Syndrome and hypersecretory disorders
- Tablet Administration:
- Oral administration for peptic ulcer, GERD, and other conditions
- Chemical Stability:
- Reconstitution and dilution guidelines for IV administration
- Dosing Regimen:
- Specified dosages for different conditions and patient profiles
- Absorption Factors:
- Potential risk of interference with Vitamin B12 absorption
- ORT Powder Mixture:
- Instructions for proper reconstitution of IV solution
- IV Infusion Duration:
- Administered over approximately 15 minutes for optimal effect
- IV Solution Preparation:
- Guidelines on dilution and admixture before IV infusion
- Regulatory Classification:
- Complies with FDA regulations for Pregnancy Category B drugs
- Adverse Reactions:
- Possible side effects include headache, diarrhea, and other uncommon symptoms
- Product Efficacy:
- Effective in treating peptic ulcers, GERD, and NSAID-induced ulcers
- Interactions Profile:
- No significant drug interactions reported in clinical trials
- Tablet Handling:
- Do not split, chew, or crush tablets for administration
- Gastric Health Benefits:
- Provides relief from acid-related conditions like ulcers and reflux disease
- Chemical Formula:
- C16H15F2N3O4S - Molecular formula of the active ingredient
- Manufacturing Specifications:
- Manufactured to pharmaceutical standards for purity and potency
- Medical Guidance:
- Consult healthcare provider for proper usage and dosing instructions
- Storage Guidelines:
- Store in a cool, dry place away from direct sunlight
- Periodic Monitoring:
- Regular check-ups to assess treatment response and side effects
Related Brands
- AUP 20 mg (Tablet (Enteric Coated)) - decent-pharma-laboratories-ltd
- AUP 40 mg (Tablet (Enteric Coated)) - decent-pharma-laboratories-ltd
- Cospra 20 mg (Tablet (Enteric Coated)) - cosmo-pharma-laboratories-ltd
- Detonix 20 mg (Tablet (Enteric Coated)) - desh-pharmaceuticals-ltd
- P-Gut 20 mg (Tablet (Enteric Coated)) - globe-pharmaceuticals-ltd